Clinical Setbacks for Toll-Like Receptor 9 Agonists in Cancer

Nat Biotechnol. 2007 Aug;25(8):825-6. doi: 10.1038/nbt0807-825. Epub 2007 Aug 2.

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic / trends*
  • Drug Approval*
  • Drug Industry / trends*
  • Humans
  • Neoplasms / drug therapy*
  • Toll-Like Receptor 9 / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • TLR9 protein, human
  • Toll-Like Receptor 9